Genworth Financial (GNW) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Q4 2025 net income was $2 million, with adjusted operating income of $8 million; full-year net income was $223 million, down from $299 million in 2024.
Enact delivered $146 million in adjusted operating income for Q4 and $558 million for 2025, with strong cure performance and capital returns.
Closed Block posted a $114 million adjusted operating loss in Q4 and $317 million loss for 2025, mainly due to LTC losses and assumption updates.
$127 million in capital returns received from Enact in Q4; $94 million in share repurchases executed in the quarter.
CareScout expanded services, launched Care Assurance (live in 39–40 states), and closed the Seniorly acquisition.
Financial highlights
Full-year 2025 adjusted operating income was $144 million, with Enact contributing $558 million.
Enact’s new insurance written reached $14 billion in Q4, with primary insurance in force at $273 billion, up 2% year-over-year.
Enact’s loss ratio was 7% in Q4, with a PMIER sufficiency ratio of 162%.
Legacy insurance companies’ risk-based capital ratio was 300% at year-end, with statutory pre-tax income of $71 million for 2025.
Holding company cash and liquid assets stood at $234 million at year-end.
Outlook and guidance
Enact expects to return ~$500 million to shareholders in 2026; new $500 million share repurchase program announced.
Planned share repurchases for 2026 are $175–$225 million, subject to market conditions.
CareScout targets 7,500 matches and at least $25 million in revenue for 2026.
Expected investment in CareScout Services is $50–$55 million in 2026, with lower incremental investment in CareScout Insurance.
Ongoing execution of LTC rate action program and development of additional risk mitigation options.
Latest events from Genworth Financial
- Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Strong 2024 results, expanded aging care, and key governance proposals drive shareholder value.GNW
Proxy Filing1 Dec 2025 - Board recommends approval of all key proposals, including director elections and compensation.GNW
Proxy Filing1 Dec 2025 - Q2 2025 net income was $51M, with $94M in capital returns and CareScout network expansion.GNW
Q2 202516 Nov 2025